Prellis Biologics Funding: $50M Raised, Series C (2022)
Prellis Biologics is a Biotech company based in Irvine, California. It has raised $50M in total funding. Latest round: Series C.
Prellis Biologics funding overview
Prellis Biologics is a Biotech company based in Irvine, California. Prellis Biologics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in August 2022. The round record for Prellis Biologics runs through 2022; nothing later has been disclosed. Investors on record include Bristol Myers Squibb, Sanofi. 2 distinct backers are named across the disclosed rounds.
Prellis Biologics at a glance
Total raised
$50M
Latest round
Series C
Latest round date
August 2022
Industry
Biotech
Headquarters
Irvine, California
Notable investors
Bristol Myers Squibb, Sanofi
Frequently asked about Prellis Biologics funding
How much has Prellis Biologics raised?
Prellis Biologics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Prellis Biologics?
Bristol Myers Squibb, Sanofi are named among the investors backing Prellis Biologics.
What was the latest Prellis Biologics funding round?
The most recent disclosed round is a Series C, announced in August 2022.
Where is Prellis Biologics based?
Prellis Biologics is based in Irvine, California.
What sector does Prellis Biologics operate in?
Prellis Biologics is tracked under Biotech from Irvine, California, with $50M in disclosed funding.
When did Prellis Biologics last raise?
The last disclosed Prellis Biologics round closed in August 2022 at Series C.
We update the Prellis Biologics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Irvine and their backers are listed below.
